129 related articles for article (PubMed ID: 38928331)
41. The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3.
Luo H; Peng C; Xu X; Peng Y; Shi F; Li Q; Dong J; Chen M
Mol Neurobiol; 2022 Apr; 59(4):2068-2084. PubMed ID: 35040040
[TBL] [Abstract][Full Text] [Related]
42. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
43. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.
Zhou Q; Liu C; Liu W; Zhang H; Zhang R; Liu J; Zhang J; Xu C; Liu L; Huang S; Chen L
Toxicol Sci; 2015 Jan; 143(1):81-96. PubMed ID: 25304210
[TBL] [Abstract][Full Text] [Related]
44. LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson's Disease Cell Model.
Zheng W; Han X; Han B; Li G; Gan J; Wang T; Xu B; He J; Du W; Cao X; Wang Z
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446291
[TBL] [Abstract][Full Text] [Related]
45. Coenzyme Q10 as a therapy for mitochondrial disease.
Hargreaves IP
Int J Biochem Cell Biol; 2014 Apr; 49():105-11. PubMed ID: 24495877
[TBL] [Abstract][Full Text] [Related]
46. Low Molecular Weight Sulfated Chitosan: Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson's Disease.
Manigandan V; Nataraj J; Karthik R; Manivasagam T; Saravanan R; Thenmozhi AJ; Essa MM; Guillemin GJ
Neurotox Res; 2019 Apr; 35(3):505-515. PubMed ID: 30426393
[TBL] [Abstract][Full Text] [Related]
47. Glycitein exerts neuroprotective effects in Rotenone-triggered oxidative stress and apoptotic cell death in the cellular model of Parkinson's disease.
Dong N; Yang Z
Acta Biochim Pol; 2022 Jun; 69(2):447-452. PubMed ID: 35691030
[TBL] [Abstract][Full Text] [Related]
48. Ginsenosides Rd and Re co-treatments improve rotenone-induced oxidative stress and mitochondrial impairment in SH-SY5Y neuroblastoma cells.
González-Burgos E; Fernández-Moriano C; Lozano R; Iglesias I; Gómez-Serranillos MP
Food Chem Toxicol; 2017 Nov; 109(Pt 1):38-47. PubMed ID: 28843595
[TBL] [Abstract][Full Text] [Related]
49. Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease.
Tamilselvam K; Braidy N; Manivasagam T; Essa MM; Prasad NR; Karthikeyan S; Thenmozhi AJ; Selvaraju S; Guillemin GJ
Oxid Med Cell Longev; 2013; 2013():102741. PubMed ID: 24205431
[TBL] [Abstract][Full Text] [Related]
50. Coenzyme q10 ameliorates ultraviolet B irradiation induced cell death through inhibition of mitochondrial intrinsic cell death pathway.
Jing L; Kumari S; Mendelev N; Li PA
Int J Mol Sci; 2011; 12(11):8302-15. PubMed ID: 22174665
[TBL] [Abstract][Full Text] [Related]
51. Agaricus blazei extract attenuates rotenone-induced apoptosis through its mitochondrial protective and antioxidant properties in SH-SY5Y neuroblastoma cells.
Venkatesh Gobi V; Rajasankar S; Ramkumar M; Dhanalakshmi C; Manivasagam T; Justin Thenmozhi A; Essa MM; Chidambaram R
Nutr Neurosci; 2018 Feb; 21(2):97-107. PubMed ID: 27646574
[TBL] [Abstract][Full Text] [Related]
52. The dilemma of diagnosing coenzyme Q
Louw R; Smuts I; Wilsenach KL; Jonck LM; Schoonen M; van der Westhuizen FH
Mol Genet Metab; 2018 Sep; 125(1-2):38-43. PubMed ID: 29530532
[TBL] [Abstract][Full Text] [Related]
53. Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT/Nrf2 pathway.
Katila N; Bhurtel S; Park PH; Choi DY
Neurochem Int; 2021 Sep; 148():105120. PubMed ID: 34197898
[TBL] [Abstract][Full Text] [Related]
54. Polydatin protects SH-SY5Y in models of Parkinson's disease by promoting Atg5-mediated but parkin-independent autophagy.
Bai H; Ding Y; Li X; Kong D; Xin C; Yang X; Zhang C; Rong Z; Yao C; Lu S; Ji L; Li L; Huang W
Neurochem Int; 2020 Mar; 134():104671. PubMed ID: 31926197
[TBL] [Abstract][Full Text] [Related]
55. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
Muthukumaran K; Leahy S; Harrison K; Sikorska M; Sandhu JK; Cohen J; Keshan C; Lopatin D; Miller H; Borowy-Borowski H; Lanthier P; Weinstock S; Pandey S
BMC Neurosci; 2014 Jan; 15():21. PubMed ID: 24483602
[TBL] [Abstract][Full Text] [Related]
56. CoQ10 Deficiency May Indicate Mitochondrial Dysfunction in Cr(VI) Toxicity.
Zhong X; Yi X; da Silveira E Sá RC; Zhang Y; Liu K; Xiao F; Zhong C
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441753
[TBL] [Abstract][Full Text] [Related]
57. Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model.
Vali S; Mythri RB; Jagatha B; Padiadpu J; Ramanujan KS; Andersen JK; Gorin F; Bharath MM
Neuroscience; 2007 Nov; 149(4):917-30. PubMed ID: 17936517
[TBL] [Abstract][Full Text] [Related]
58. Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells.
Chung WG; Miranda CL; Maier CS
Brain Res; 2007 Oct; 1176():133-42. PubMed ID: 17900545
[TBL] [Abstract][Full Text] [Related]
59. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10.
McCarthy S; Somayajulu M; Sikorska M; Borowy-Borowski H; Pandey S
Toxicol Appl Pharmacol; 2004 Nov; 201(1):21-31. PubMed ID: 15519605
[TBL] [Abstract][Full Text] [Related]
60. Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.
Arnold B; Cassady SJ; VanLaar VS; Berman SB
Neurobiol Dis; 2011 Jan; 41(1):189-200. PubMed ID: 20850532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
